BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Oct. 24, 2025

Oct. 24, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Adverum, Biogen, Cassava, Eli Lilly, Sanofi, Vanqua.
Read More

Other news to note for Oct. 23, 2025

Oct. 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiopro, Cormedix, Emboline, Euda Health, Inspira Technologies, Nauticus, Neurent Medical, Omed Health, Owlstone Medical, Profusa.
Read More

Other news to note for Oct. 23, 2025

Oct. 23, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: AAX, Biossil, Daiichi Sankyo, Forlong, Galera, Henlius, Kyowa Kirin.
Read More

Other news to note for Oct. 23, 2025

Oct. 23, 2025
Additional early-stage research and drug discovery news in brief, from: Lakewood-Amedex, Simcha Therapeutics.
Read More

Other news to note for Oct. 22, 2025

Oct. 22, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ainnova, Becton Dickinson, Femasys, Histosonics, Innerscope, Nyra, Ventric.
Read More

Other news to note for Oct. 22, 2025

Oct. 22, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Arrowhead, Austrianova, Avant, CSL, Galapagos, Novartis, Pacira, Purdue, Roche, Teli, Telomir, Teva, Ventus.
Read More

Other news to note for Oct. 21, 2025

Oct. 21, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, Anthropic, Cardio Diagnostics, Hyperfine, Integrated DNA, Nucleus Genomics, Profluent Bio.
Read More

Other news to note for Oct. 21, 2025

Oct. 21, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Contera, Cumberland Pharma, H. Lundbeck, Lava, Redhill, Xoma Royalty.
Read More

Other news to note for Oct. 21, 2025

Oct. 21, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Actor, Aculys, Chugai, Cytomed Therapeutics, Formycon, Gilead, Hansoh, Jacobio, Jacoray, Kite, Klinge, Megalabs, Nabla, Novo Nordisk, Rani, Roche, Scisparc, Shenzen Pregene, Sumitomo, Takeda, TC Biopharm, Viatris, Vectus, Xortx.
Read More

Other news to note for Oct. 20, 2025

Oct. 20, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: A.D.A.M. Innovations, Celltrion, Genedx, Rhythio Medical, Sophia Genetics, Wellscare.
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 1383 1384 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 30, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing